Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity

Cell(2024)10.1016/j.cell.2024.04.025Source: DataRank Database

ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity is a research paper published in Cell (2024). On theSindex it has a DataRank of 0. It has been cited 118 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access118 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 19.61)OA: greenTopics (64)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Marianne S. Hom ORCID,Jawoon Yi ORCID,Shitian Li ORCID,Samuel A. Rivera ORCID,Jingting Yu ORCID

Live enrichment

PubMed:38754421 PMC:PMC11193641 OpenAlex:https://openalex.org/W4396939672

Merck

Grant: R21 MH128678

Merck

Grant: R01 CA228211

Merck

Grant: R01AI066232

Merck

Grant: R01 CA285867

Merck

Grant: R01 CA240909

Merck

Grant: R01 CA216101

Merck

Grant: 4045

National Institutes of Health

Grant: T32DK007541

NCI NIH HHS

Grant: P30 CA014195

NIH HHS

Grant: S10 OD023689

Howard Hughes Medical Institute

National Genealogical Society

American Cancer Society

Franklin County Community Foundation

PEW Charitable Trusts

Cancer Research Institute

National Science Foundation

FWCI

19.61

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11193641/pdf/nihms-1988787.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867424004513?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867424004513?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11193641

Fields of Study

Chromatin Remodeling and Cancerinterferon and immune responsesCancer Mechanisms and TherapyAnimalsHumansMiceCD8-Positive T-LymphocytesCell Line, TumorDNA-Binding ProteinsExodeoxyribonucleasesImmune Checkpoint InhibitorsInterferon Type IMembrane ProteinsMice, Inbred C57BLMutationNeoplasmsNuclear ProteinsPhosphoproteinsSignal TransductionTranscription FactorsMaleChemokinesSTING Protein

MeSH Terms

Immune Checkpoint InhibitorsSTING ProteinAnimalsDNA-Binding ProteinsExodeoxyribonucleasesFemaleHumansInterferon Type IMaleMembrane ProteinsMice, Inbred C57BLMutationNeoplasmsNuclear ProteinsPhosphoproteinsTranscription FactorsSignal TransductionCD8-Positive T-LymphocytesChemokinesCell Line, TumorMice

Keywords

ARID1ABiologyCancer researchDownregulation and upregulationInterferonStingMicrosatellite instabilityMutantImmune systemMolecular biologyGeneImmunologyMutationGeneticsAnti-tumor immunityCancer ImmunotherapyR-loopsSwi/snf ComplexType I IfnCytosolic Dna

Sustainable Development Goals

SDG 0: Good health and well-being